Skip to content

Phototherapeutic Keratectomy (PTK) With Mitomycin in Adenoviral Opacities

Phototherapeutic Keratectomy With Mitomycin C in Adenoviral Infiltrates

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00492245
Enrollment
30
Registered
2007-06-27
Start date
2006-04-30
Completion date
2008-12-31
Last updated
2008-08-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Corneal Opacity, Keratitis

Keywords

PTK, corneal opacity, mitomycin

Brief summary

The present study was designed to evaluate the treatment of adenoviral corneal opacities with PTK and mitomycin C.

Detailed description

Epidemic keratoconjunctivitis is a very common disease, some patients developed a complication after the infection wich is corneal infiltration. Topical treatment sometimes helps to avoid loss of visual acuity. Therefore recurrence of the opacities after topical drops is observed. When corneal fibrosis occur is difficult to achieve visual rehabilitation with topical approach. This study evaluate pre and postoperative data of patients with subepithelial fibrosis caused by adenoviral infiltrates submitted to phototherapeutic keratectomy (PTK) using mitomycin C.

Interventions

PROCEDUREPTK with mitomycin in Adenoviral Opacities

Sponsors

Federal University of São Paulo
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* visual acuity worse than 20/40, caused by central subepithelial fibrosis

Exclusion criteria

* pregnancy, age less than 18 years-old or more than 80 years-old. * diabetes, autoimmune diseases, corneal thickness less tha 400 micron.

Design outcomes

Primary

MeasureTime frame
Refractive data, visual acuity, slit lamp findings, subjective evaluation, topography patterns, pachymetry measurements.one year

Secondary

MeasureTime frame
wavefront analysis, anterior segment tomography data, corneal biomechanics data.one year

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026